Preventing blindness in retinal disease: Ciliary neurotrophic factor intraocular implants

Ian M. MacDonald, Yves Sauvé, Paul A. Sieving

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

A recent phase I trial of an encapsulated cell therapy device that delivers ciliary neurotrophic factor has shown the potential of this approach in the treatment of retinitis pigmentosa. As experience with this device is gained, other retinal degenerative disorders may be potential targets of a similar therapeutic approach.

Original languageEnglish (US)
Pages (from-to)399-402
Number of pages4
JournalCanadian Journal of Ophthalmology
Volume42
Issue number3
DOIs
StatePublished - Jun 2007
Externally publishedYes

Keywords

  • Ciliary neurotrophic factor
  • Encapsulated cell therapy
  • Macular degeneration
  • Neuroprotection
  • Retina
  • Retinitis pigmentosa

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Preventing blindness in retinal disease: Ciliary neurotrophic factor intraocular implants'. Together they form a unique fingerprint.

Cite this